Pejman Rowshanfarzad
Overview
Explore the profile of Pejman Rowshanfarzad including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
73
Citations
384
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jones X, Neveri G, Chin M, Rowshanfarzad P
Phys Med Biol
. 2025 Mar;
PMID: 40081011
Objective
Intraoperative radiotherapy (IORT) is a specialised radiotherapy technique that delivers a precise, single high-dose fraction to the tumour bed after surgical removal of the tumour, aiming to eliminate residual cancer...
2.
Rusanov B, Ebert M, Sabet M, Rowshanfarzad P, Barry N, Kendrick J, et al.
Phys Eng Sci Med
. 2025 Jan;
PMID: 39804550
Artificial Intelligence (AI) based auto-segmentation has demonstrated numerous benefits to clinical radiotherapy workflows. However, the rapidly changing regulatory, research, and market environment presents challenges around selecting and evaluating the most...
3.
Barry N, Kendrick J, Molin K, Li S, Rowshanfarzad P, Hassan G, et al.
Eur Radiol
. 2025 Jan;
35(3):1701-1713.
PMID: 39794540
Objectives: Conduct a systematic review and meta-analysis on the application of the Radiomics Quality Score (RQS). Materials And Methods: A search was conducted from January 1, 2022, to December 31,...
4.
DAlonzo R, Keam S, Gill S, Rowshanfarzad P, Nowak A, Ebert M, et al.
Cancer Immunol Immunother
. 2025 Jan;
74(2):44.
PMID: 39751851
Combination immune checkpoint inhibitors (nivolumab and ipilimumab) are currently a first-line treatment for mesothelioma; however, not all patients respond. The efficacy of treatment is influenced by the tumor microenvironment. Murine...
5.
Pikes G, Dass J, Gill S, Ebert M, Ebert M, Reynolds M, et al.
Phys Med Biol
. 2025 Jan;
70(2.
PMID: 39746308
FLASH radiotherapy employs ultra-high dose rates of>40Gy s, which may reduce normal tissue complication as compared to conventional dose rate treatments, while still ensuring the same level of tumour control....
6.
DAlonzo R, Keam S, Hoang T, Gill S, Rowshanfarzad P, Nowak A, et al.
In Vivo
. 2024 Dec;
39(1):55-79.
PMID: 39740867
Background/aim: Tumors exhibit impaired blood flow and hypoxic areas, which can reduce the effectiveness of treatments. Characterizing these tumor features can inform treatment decisions, including the use of vasculature modulation...
7.
Lee A, Alkhatib Z, Ibrahim M, McCallum-Hee B, Dass J, Fernandez de Viana M, et al.
J Appl Clin Med Phys
. 2024 Sep;
25(12):e14520.
PMID: 39284207
Purpose: Total skin electron therapy (TSET) is a complex radiotherapy technique, posing challenges in commissioning and quality assurance (QA), especially due to significant variability in patient body shapes. Previous studies...
8.
Mukwada G, Chamunyonga C, Rowshanfarzad P, Gill S, Ebert M
PLoS One
. 2024 Aug;
19(8):e0307088.
PMID: 39121064
Background: GammaKnife (GK) and CyberKnife (CK) have been the mainstay stereotactic radiosurgery (SRS) solution for multiple brain metastases (MBM) for several years. Recent technological advancement has seen an increase in...
9.
Ng A, MacKinnon K, Cook A, DAlonzo R, Rowshanfarzad P, Nowak A, et al.
Phys Eng Sci Med
. 2024 Jul;
47(4):1291-1306.
PMID: 39017990
Immunotherapy is a rapidly evolving field, with many models attempting to describe its impact on the immune system, especially when paired with radiotherapy. Tumor response to this combination involves a...
10.
Riis H, Engstrom K, Slama L, Dass J, Ebert M, Rowshanfarzad P
Phys Eng Sci Med
. 2024 Jul;
47(4):1361-1383.
PMID: 38954381
A fundamental parameter to evaluate the beam delivery precision and stability on a clinical linear accelerator (linac) is the focal spot position (FSP) measured relative to the collimator axis of...